Preactivation of Jurkat T cells with anti-CD2/CD3/CD28 antibodies that mimic the stimulating signal produced by APCs led to a statistically increased viability of tumor-derived cells after 14 days of culture (Table S2). This evidence concerns the gene CD2 and neoplasm.